Treating BRCA1/2 Metastatic Breast Cancer - Metastatic Breast Cancer Trial Talk

MBC News

Reading this article from Breastcancer.org along with the FDA’s press release and a viewpoint by cancer writer Elaine Schattner, provides three perspectives and good context for women with BRCA+ metastatic breast cancer wondering if Lynparza is right for them.

Tags:

SEARCH OUR SITE

for past articles or specific information.